Work

Supplemental Material for: Severe idiosyncratic drug-induced liver injury to Rivaroxaban and positive rechallenge with apixaban

Year: 2026
Type: supplementary-materials
Abstract: Introduction: Rivaroxaban, a direct oral factor Xa inhibitor, is widely used for the prevention and treatment of thromboembolic disorders. Although generally well tolerated, rare cases of drug-induced liver injury (DILI) have been reported. The potential for cross-reactivity with other direct oral anticoagulants (DOACs) remains poorly documented. Case Presentation: We report the case of a 76-year-old woman with hypertension and cardiac arrhythmia who developed severe acute DILI six months after initiation of rivaroxaban therapy. She presented with jaundice and marked elevation of liver enzymes (AST 19× upper normal limit, ALT 9× upper normal limit) and hyperbilirubinemia (20× upper normal limit), associated with impaired prothrombin time (<10%). Viral, autoimmune, and obstructive causes were excluded. Rivaroxaban-induced severe DILI was suspected, and the drug was discontinued, resulting in progressive clinical and biochemical recovery within three weeks. Causality assessment using the Naranjo scale and RUCAM score indicated a probable relationship. Six months later, following a cerebrovascular ischemic event, apixaban was introduced. Within four days, liver enzymes and coagulation parameters worsened again, suggesting possible cross-reactivity. Apixaban was immediately discontinued and replaced with acenocoumarol, leading to favorable outcome. Conclusion: This case highlights severe rivaroxaban-induced hepatotoxicity with a possible relapse following apixaban exposure, suggesting potential class-related hepatotoxicity among factor Xa inhibitors. Clinicians should be aware of this rare but serious adverse effect and exercise caution when switching between DOACs in patients with a history of anticoagulant-induced liver injury.
Source: Figshare
Language: English
Subfield: Pharmacology
Open Access status: green
OpenAlex ID: W7203909378
Cites:
Cited by:
Related to: 10